
Schrödinger, Inc. is a life sciences software and biotechnology company that develops a physics-based computational platform for molecular discovery. The company provides software tools used to model and simulate chemical and biological systems, helping researchers identify and optimize novel molecules for drug discovery and materials science. Its platform is used across the pharmaceutical, biotechnology, materials, and industrial research sectors, supporting workflows such as molecular design, simulation, and collaboration. Schrödinger also operates a drug discovery segment that applies its technology to proprietary and partnered research programs. Headquartered in New York and founded in 1990, Schrödinger plays a specialized role in the market as a provider of advanced computational chemistry solutions for scientific innovation.
www.schrodinger.com